AU2003236346A1 - Monoclonal antibody neutralizing megsin - Google Patents

Monoclonal antibody neutralizing megsin

Info

Publication number: AU2003236346A1
Authority: AU; Australia
Prior art keywords: megsin; monoclonal antibody; antibody neutralizing; neutralizing; monoclonal
Prior art date: 2002-04-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003236346A

Inventor

Masahiro Asakura

Takeshi Chisaka

Yumi Hirooka

Kazuya Kunitou

Kiyoshi Kurokawa

Toshio Miyata

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Fuso Pharmaceutical Industries Ltd

Original Assignee

Fuso Pharmaceutical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-11

Filing date

2003-04-08

Publication date

2003-10-20

2003-04-08 Application filed by Fuso Pharmaceutical Industries Ltd filed Critical Fuso Pharmaceutical Industries Ltd

2003-10-20 Publication of AU2003236346A1 publication Critical patent/AU2003236346A1/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

AU2003236346A 2002-04-11 2003-04-08 Monoclonal antibody neutralizing megsin Abandoned AU2003236346A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002-108924		2002-04-11
JP2002108924		2002-04-11
PCT/JP2003/004459 WO2003084998A1 (en)	2002-04-11	2003-04-08	Monoclonal antibody neutralizing megsin

Publications (1)

Publication Number	Publication Date
AU2003236346A1 true AU2003236346A1 (en)	2003-10-20

Family

ID=28786549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003236346A Abandoned AU2003236346A1 (en)	2002-04-11	2003-04-08	Monoclonal antibody neutralizing megsin

Country Status (3)

Country	Link
JP (1)	JP4225487B2 (en)
AU (1)	AU2003236346A1 (en)
WO (1)	WO2003084998A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7767792B2 (en) *	2004-02-20	2010-08-03	Ludwig Institute For Cancer Research Ltd.	Antibodies to EGF receptor epitope peptides
JPWO2006093128A1 (en) *	2005-02-28	2008-08-07	学校法人東海大学	Anti megsin monoclonal antibody
WO2006121047A1 (en) *	2005-05-09	2006-11-16	Tokai University Educational System	Method for determination of megsin in biological sample

2003
- 2003-04-08 AU AU2003236346A patent/AU2003236346A1/en not_active Abandoned
- 2003-04-08 JP JP2003582192A patent/JP4225487B2/en not_active Expired - Fee Related
- 2003-04-08 WO PCT/JP2003/004459 patent/WO2003084998A1/en active Application Filing

Also Published As

Publication number	Publication date
WO2003084998A1 (en)	2003-10-16
JP4225487B2 (en)	2009-02-18
JPWO2003084998A1 (en)	2005-08-11

Similar Documents

Publication	Publication Date	Title
AU2003264009A1 (en)	2004-03-03	Humanized rabbit antibodies
AU2003217912A1 (en)	2003-09-16	Antibody optimization
AU2003259294A1 (en)	2004-02-16	Humanized antibodies against human 4-1bb
EP1494693A4 (en)	2006-08-02	Cripto-specific antibodies
AU2002251562A1 (en)	2003-04-17	Anti-CD40 monoclonal antibody
AU2002256895A1 (en)	2003-05-08	Anti-TRAIL-R antibodies
HK1153763A1 (en)	2012-04-05	Anti-her2 antibody variants
PL375405A1 (en)	2005-11-28	Antibodies
IL165256A0 (en)	2005-12-18	Neutralizing human anti-igfr antibody
IL215011A0 (en)	2011-10-31	Neutralizing antibodies against gdf-8 and uses therefor
EP1572077A3 (en)	2005-08-11	Uses of monoclonal antibody 8h9
AU2002365649A1 (en)	2003-06-17	Anti-dota antibody
AU2003220079A1 (en)	2003-09-22	Uses of monoclonal antibody 8h9
EP1598368A4 (en)	2007-07-25	Anti-pci neutralizing antibodies
AU2003277832A1 (en)	2004-05-25	Humanized tissue factor antibodies
AU2003275834A1 (en)	2003-12-31	ANTIBODIES THAT BIND alphaE INTEGRIN
IL163580A0 (en)	2005-12-18	Assay for anti-ingap antibodies
AU2003229799A1 (en)	2003-11-17	Novel humanized anti-vap-1 monoclonal antibody
GB0306618D0 (en)	2003-04-30	Antibody
AU2003236346A1 (en)	2003-10-20	Monoclonal antibody neutralizing megsin
AU2003271093A1 (en)	2004-11-01	Antigen recognizing antibody
GB0226878D0 (en)	2002-12-24	Antibodies
GB0218232D0 (en)	2002-09-11	Antibodies
GB0218229D0 (en)	2002-09-11	Antibodies
GB0218230D0 (en)	2002-09-11	Antibodies

Legal Events

Date	Code	Title	Description
2005-01-27	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase